These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2093544)
21. L-Carnitine effects on anemia in uremic rats treated with erythropoietin. Azzadin A; Wollny T; Pawlak R; Malyszko JS; Malyszko J; Myśliwiec M; Buczko W Nephron; 1999; 83(4):370-1. PubMed ID: 10575305 [No Abstract] [Full Text] [Related]
22. Does anemia correction by rHuEPO improve uremic cardiopathy? Carletti P; Bibiano L; Boggi R; Taruscia D; Mioli V Kidney Int Suppl; 1993 Jun; 41():S70-1. PubMed ID: 8320949 [TBL] [Abstract][Full Text] [Related]
23. Resistance to erythropoietin. Lacombe C N Engl J Med; 1996 Mar; 334(10):660-2. PubMed ID: 8592534 [No Abstract] [Full Text] [Related]
24. Subcutaneous low doses of recombinant human erythropoietin in predialysis patients do not interfere with the progression of renal failure. Savica V; Costantino G; Monardo P; Bellinghieri G Am J Nephrol; 1995; 15(1):10-4. PubMed ID: 7872358 [TBL] [Abstract][Full Text] [Related]
25. Erythropoietin for zidovudine-induced anemia. N Engl J Med; 1990 Oct; 323(15):1069-70. PubMed ID: 2215568 [No Abstract] [Full Text] [Related]
26. Effect of serum parathyroid hormone and aluminum levels on the response to erythropoietin in uremia. Ifudu O; Homel P Nephron; 1998 Aug; 79(4):477-8. PubMed ID: 9689168 [No Abstract] [Full Text] [Related]
27. Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin. Moia M; Mannucci PM; Vizzotto L; Casati S; Cattaneo M; Ponticelli C Lancet; 1987 Nov; 2(8570):1227-9. PubMed ID: 2890852 [TBL] [Abstract][Full Text] [Related]
28. Treatment with recombinant human erythropoietin in patients with aluminum overload and hyperparathyroidism. Grützmacher P; Ehmer B; Limbach J; Messinger D; Kulbe KD; Scigalla P Blood Purif; 1990; 8(5):279-84. PubMed ID: 2091687 [TBL] [Abstract][Full Text] [Related]
29. Aluminium intoxication in the rat induces partial resistance to the effect of recombinant human erythropoietin. Losekann A; Ureña P; Khiraoui F; Casadevall N; Zins B; Bererhi L; Zingraff J; Bourdon R; Drüeke T Nephrol Dial Transplant; 1990; 5(4):258-63. PubMed ID: 2113221 [TBL] [Abstract][Full Text] [Related]
30. Recombinant erythropoietin for zidovudine-induced anemia in AIDS. Kuehl AK; Noormohamed SE Ann Pharmacother; 1995; 29(7-8):778-9. PubMed ID: 8520096 [TBL] [Abstract][Full Text] [Related]
31. [The treatment of renal anemia]. Koch KM Verh Dtsch Ges Inn Med; 1989; 95():246-8. PubMed ID: 2603482 [No Abstract] [Full Text] [Related]
32. [The use of erythropoietin in HIV myelodysplasias. Preliminary study]. Fruttaldo L; Gatti G; Deambrogio V; Mongiò F; Schettino G; Cavagnolo G Minerva Med; 1993 Mar; 84(3):103-5. PubMed ID: 8492960 [TBL] [Abstract][Full Text] [Related]
33. [Effect of deferoxamine on erythropoiesis in patients hemodialyzed for chronic renal insufficiency treated with erythropoietin]. Kalinowski M; Popławski A; Kaliszewski Z; Juzwiuk J Pol Merkur Lekarski; 1996 Oct; 1(4):232-4. PubMed ID: 9156931 [TBL] [Abstract][Full Text] [Related]
35. Effect of erythropoietin administration in uremia. Gurland HJ; Samtleben W; Schmidt B Contrib Nephrol; 1989; 70():172-7. PubMed ID: 2670428 [No Abstract] [Full Text] [Related]
36. Effects of the evening i.v. administration of erythropoietin in haemodialyzed patients. Buemi M; Allegra A; Laganà A; Aloisi C; Privitera M; Morabito N; Frisina N Riv Eur Sci Med Farmacol; 1993; 15(5-6):195-7. PubMed ID: 7761669 [TBL] [Abstract][Full Text] [Related]